All Posts By

Smartkarma Daily Briefs

Daily Brief Energy/Materials: Ecopro Co Ltd, Asia Cement, Essential Metals and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • What We Know Until Now About L&F & Ecopro BM’s Kospi Transfer Listing
  • Quiddity Leaderboard TDIV Sep 23: AUM Assumption Changes Again; SHORTs Down 15.6% Vs Index
  • Essential Metals/Develop Global: Rock Steady With MinRes Support


What We Know Until Now About L&F & Ecopro BM’s Kospi Transfer Listing

By Sanghyun Park

  • Yonhap News reported on the exclusive coverage of Ecopro BM and L&F’s KOSPI transfer listing.
  • L&F announced through the disclosure that they are considering the KOSPI transfer listing. Ecopro BM told another local news outlet that they are not currently reviewing the KOSPI transfer listing.
  • It seems that L&F’s KOSPI transfer listing is almost a confirmed fact. However, the Ecopro company in question may be Ecopro Co, not Ecopro BM.

Quiddity Leaderboard TDIV Sep 23: AUM Assumption Changes Again; SHORTs Down 15.6% Vs Index

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at Quiddity’s flow expectations for the September 2023 index rebalance.
  • Since my last insight, my estimate for the tracking AUM estimate assumption for September 2023 has increased and has caused changes to my flow expectations.
  • Separately, the SHORTs suggested in my last insight have underperformed the index by 15.6% in 3 weeks. I have updated my thoughts on that as well.

Essential Metals/Develop Global: Rock Steady With MinRes Support

By David Blennerhassett

  • At the 20 April Scheme Meeting, Mineral Resources (MIN AU) (with 19.55%) and other shareholders voted against the Tianqi Lithium JV transaction for Essential Metals (ESS AU)
  • This left Essential in no man’s land until MinRes (presumably) made a move. But on the 3 July, Develop Global (DVP AU) announced a binding Scheme with ESS.
  • The all-scrip Scheme transaction has the backing of MinRes, which also owns a ~13% stake in Develop. This deal – this time- looks all stitched up.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Lalatech Holdings Co Ltd, Tokyo Stock Exchange Tokyo Price Index Topix, Rookie International, Neu Battery Materials and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Lalatech IPO: The Bear Case
  • The Format of the AGM Also Reveals a Part of the Company’s Attitude Toward Its Shareholders
  • Rookie International Pre-IPO Tearsheet
  • NEU Battery Materials Scores US$3.7M for Sustainable Recycling of Li-Ion Batteries


Lalatech IPO: The Bear Case

By Arun George

  • Lalatech Holdings Co Ltd (LALA HK), a leading logistics transaction platform, has filed for an HKEx IPO to raise US$1 billion, according to press reports.  
  • In Lalatech IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The key elements of the bear case rest on market share pressure, KPIs declining growth, declining revenue visibility, maiden profitability built on a shaky foundation and barely positive underlying FCF. 

The Format of the AGM Also Reveals a Part of the Company’s Attitude Toward Its Shareholders

By Aki Matsumoto

  • Even if attendance increases somewhat since 92.1% of AGMs in 2022 had less than 100 attendees, the reluctance to hold an online voting AGM due to technical issues isn’t reasonable.
  • With 84.8% of companies having Q&A sessions lasting less than 30 minutes, many companies want to end their Q&A sessions in as short a time as possible.
  • Companies that want to keep Q&A sessions short tend to hold hybrid on-site and online sessions that can prioritize questions from on-site attendees and limit questions from online participants.

Rookie International Pre-IPO Tearsheet

By Ethan Aw

  • Rookie International (1962144D CH) is looking to raise at least US$100m in its upcoming HK IPO. The deal will be run by Citic Securities and CMBI. 
  • Rookie International is a fully-integrated operator of childrenswear brands in Greater China. It operates a portfolio of childrenswear brands, by designing, manufacturing and distributing branded products in Greater China. 
  • It generates revenue primarily by selling licensed products which it has self-designed or curated under the brands (for which it has access to licenses) in Greater China. 

NEU Battery Materials Scores US$3.7M for Sustainable Recycling of Li-Ion Batteries

By e27

  • NEU Battery Materials, a Singapore-based lithium-ion battery recycling startup, has secured US$3.7 million in an oversubscribed seed funding round led by SGInnovate.
  • ComfortDelGro Ventures, Shift4Good, Paragon Ventures I, and other angel investors also joined.
  • These funds will accelerate the deployment of NEU Battery Materials’s automated recycling line, which will lower operational manpower requirements.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Imugene Ltd, Immix Biopharma Inc, Numinus Wellness, Teva Pharmaceutical Sp Adr and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Imugene (IMU AU): Got US Patent for Oncolytic Virotherapy- A Crucial Step Forward for US Entry
  • Immix Biopharma – IMX-110 interim results in colorectal cancer
  • Numinus Wellness, Inc. – A Quarter of Strong Growth; Focus on Cash Burn Reduction
  • Teva – ESG Report – Lucror Analytics


Imugene (IMU AU): Got US Patent for Oncolytic Virotherapy- A Crucial Step Forward for US Entry

By Tina Banerjee

  • Imugene Ltd (IMU AU) got US patent for its oncolytic virotherapy CF33 products, including VAXINIA and CHECKVacc. The patent protects the method of composition and use of CF33 until 2037.
  • Imugene has appointed two-decade experienced Dr Ron Weitzman as Interim Chief Medical Officer. Dr Weitzman’s expertise in solid-tumor and hematologic malignancies is of particular interest for Imugene.
  • Imugene is actively recruiting patients for its five ongoing clinical trials. The company has a strong balance sheet holding more than A$150 million in cash, providing a runway through 2025.

Immix Biopharma – IMX-110 interim results in colorectal cancer

By Edison Investment Research

Immix has shared interim data from the Phase Ib/IIa trial evaluating IMX-110 in combination with tislelizumab for solid tumors. As of the data cut-off (7 July 2023), it was found that three of four participants with metastatic colorectal cancer (mCRC) showed tumor shrinkage and one of four experienced tumor control; all patients had stage IV relapsed/refractory (r/r) mCRC and had received a median eight lines of prior therapy. Dose escalation is proceeding, and dosing of the second cohort of patients in the Phase Ib portion of this study is complete. The higher dose cohort (Cohort 3) of patients with solid tumors is currently being enrolled, aiming to establish the recommended Phase II dose. With no severe adverse events reported to date, and with the early signs of efficacy, we believe these results are encouraging for the clinical development of IMX-110. We anticipate a steady flow of data readouts throughout H223 and FY24.


Numinus Wellness, Inc. – A Quarter of Strong Growth; Focus on Cash Burn Reduction

By Water Tower Research

  • Strong sequential revenue growth. Numinus’ fiscal third quarter ended May 31, 2023, delivered revenues of C$6M, a 713% increase from the year ago quarter which was prior to the Novamind acquisition.
  • Of greater significance, the company delivered double-digit sequential growth of 12.6%, highlighting the growth track in demand for its clinic and clinical research offerings.
  • On this basis, revenues generated across Numinus’ wellness clinics in the US and Canada grew by 5.5% Q/Q, while its clinical research operations (CCR) recorded a sequential revenue surge of 66.7%, as a result of which the division’s share of total revenues climbed to 17% from the prior quarter’s 12%.

Teva – ESG Report – Lucror Analytics

By Charles Macgregor

  • Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
  • We assess Teva’s ESG as “Adequate”, in line with its “Adequate” Environmental and Social scores. The company has “Strong” Governance. Controversies are “Material”, but Disclosure is “Strong”.
  • Teva Pharmaceutical Industries Limited is a global company that develops, produces and markets generic medicines and a focused portfolio of speciality medicines.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Neuren Pharmaceuticals, Data#3 Ltd, Ecopro Co Ltd, Invincible Investment, Rakuten Securities, L&F Co Ltd, Wisdom Marine Lines, HMM Co., Ltd. and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY
  • S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September
  • What We Know Until Now About L&F & Ecopro BM’s Kospi Transfer Listing
  • Invincible Investment Corp Placement – Decent Accretion Despite the Large Dilution
  • Rakuten Securities IPO Early Look – The Positives – Has Been Gaining Market Share
  • L&F Considering On Switching Listing from KOSDAQ to KOSPI
  • Yuanta ETFs Rebalance Preview: Soaring Stocks, Rising Shorts; AI Beats Shipping
  • Investigating HMM’s Latest Bond Conversion Situation for a Shorting Setup
  • Quiddity Leaderboard T50/​​100 Sep 23: AI Frenzy Causes Many Changes to Expectations
  • Ohayo Japan |Inflation Moderation Drives Stocks; NUGGET:JP Office Equip Makers- Consolidation a Must


Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY

By Brian Freitas


S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September

By Brian Freitas


What We Know Until Now About L&F & Ecopro BM’s Kospi Transfer Listing

By Sanghyun Park

  • Yonhap News reported on the exclusive coverage of Ecopro BM and L&F’s KOSPI transfer listing.
  • L&F announced through the disclosure that they are considering the KOSPI transfer listing. Ecopro BM told another local news outlet that they are not currently reviewing the KOSPI transfer listing.
  • It seems that L&F’s KOSPI transfer listing is almost a confirmed fact. However, the Ecopro company in question may be Ecopro Co, not Ecopro BM.

Invincible Investment Corp Placement – Decent Accretion Despite the Large Dilution

By Sumeet Singh

  • Invincible Investment (8963 JP) plans to raise around US$230m to fund the acquisition of six hotel assets in Japan.
  • The stock has done well over the past year and so have most of its deals which we have covered in the past.
  • In this note, we talk about the deal dynamics and run the deal through our ECM framework.

Rakuten Securities IPO Early Look – The Positives – Has Been Gaining Market Share

By Sumeet Singh

  • Rakuten Securities (RAKUSEC JP), the online securities arm of Rakuten, aims to raise around US$500m (estimated) in its Japan listing.
  • It is the largest online securities firm in Japan with a 33.7% market share. In FY22, it had over 8.64m accounts, with around JPY18.2tn (US$131bn) of assets under custody.
  • In this note, we talk about the positive aspects of the deal.

L&F Considering On Switching Listing from KOSDAQ to KOSPI

By Douglas Kim

  • On 19 July, there were local media accounts that L&F Co Ltd (066970 KS) is considering on switching its listing from KOSDAQ to KOSPI. 
  • L&F’s main business involves making cathode active materials for rechargeable batteries.
  • Despite this positive move, we believe the valuations of L&F have become too high. Its operating margins also worsened from 9.6% in 1Q 2022 to 3.0% in 1Q 2023. 

Yuanta ETFs Rebalance Preview: Soaring Stocks, Rising Shorts; AI Beats Shipping

By Brian Freitas

  • Using data from the close on 19 July, there could be 5 changes to the Yuanta/​P-Shares Taiwan Top 50 ETF and 2 deletions for the Yuanta/​P-Shares Taiwan Dividend Plus ETF.
  • Stocks that are expected to benefit from the AI revolution could gain ETF inclusion while shipping stocks are the ones expected to be deleted from the ETF.
  • There has been a huge increase in shorts on some of the potential inclusions and on most of the potential deletions. That will affect how stocks trade near term.

Investigating HMM’s Latest Bond Conversion Situation for a Shorting Setup

By Sanghyun Park

  • Those that the local market is particularly interested in are the 192nd convertible bonds (CB) held by KDB, along with the 193rd bonds with warrants (BW) owned by KOBC.
  • These two bonds’ call option exercise date is September 25th. Upon conversion of these bonds, 200M new shares will be issued (41% of SO and a 30% dilution).
  • The key is the trade-off between not disrupting the selling process and avoiding any breach of trust. The prevailing local sentiment suggests that KDB and KOBC will choose stock conversion.

Quiddity Leaderboard T50/​​100 Sep 23: AI Frenzy Causes Many Changes to Expectations

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the names leading the race to become ADDs/DELs for the T50 and T100 Indices for the September 2023 Rebalance.
  • Some semiconductor/electronic component stocks have seen their share prices skyrocket in recent months due to AI-related excitement causing drastic shifts in Leaderboard rankings.
  • In my last insight, I expected two T50 changes and one T100 change. Now I expect five T50 changes and three T100 changes.

Ohayo Japan |Inflation Moderation Drives Stocks; NUGGET:JP Office Equip Makers- Consolidation a Must

By Mark Chadwick

  • OVERSEAS.  SPX eaks out gains as markets continue to bid inflation moderation/soft landing narrative; GS Reports the futures is better; TELSA earnings beat despite aggressive price cuts
  • JAPAN. Nikkei Futures flat vs Cash; USDJPY 139.7; Inbound Tourist back in full force; Daily Goods Manufacturers form logistics alliance to combat lack of drivers; Nidec, Disco reports today
  • NUGGET. JP Office Equipment Makers – could be investment opportunities if they are proactive consolidation. Falling demand and overcapacity demands aggressive industry restructuring.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Singapore: NodeFlair and more

By | Daily Briefs, Singapore

In today’s briefing:

  • NodeFlair Gets US$2M in Series A Funding to Further Expand, Accelerate Product Development


NodeFlair Gets US$2M in Series A Funding to Further Expand, Accelerate Product Development

By e27

  • NodeFlair, a Singapore-based career advancement platform for tech talents, announced today that it has raised US$2 million Series A funding.
  • The funding round was led by Iterative with participation from 500 Global and PERSOL VENTURE PARTNERS, the corporate venture capital arm of HR management group PERSOL.
  • Prominent angel investors Quek Siu Rui (CEO & Co-founder of Carousell), JJ Chai (CEO & Co-founder of Rainforest), and Siew Kum Hong (Former COO of AirBnB China) also participated in the funding round.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: SK Ecoplant, HMM Co., Ltd. and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Initial Thoughts on the SK Ecoplant IPO – Impact on SK Inc
  • Investigating HMM’s Latest Bond Conversion Situation for a Shorting Setup


Initial Thoughts on the SK Ecoplant IPO – Impact on SK Inc

By Douglas Kim

  • SK Ecoplant is getting ready to complete its IPO sometime in late 2023/1H 2024.
  • Local media have mentioned that SK Ecoplant’s market cap could range from 5 trillion won to 10 trillion won.
  • At the end of 2022, SK Inc’s 44.5% stake in SK Ecoplant had a book value of 545 billion won, which is much less the market value of SK Ecoplant.

Investigating HMM’s Latest Bond Conversion Situation for a Shorting Setup

By Sanghyun Park

  • Those that the local market is particularly interested in are the 192nd convertible bonds (CB) held by KDB, along with the 193rd bonds with warrants (BW) owned by KOBC.
  • These two bonds’ call option exercise date is September 25th. Upon conversion of these bonds, 200M new shares will be issued (41% of SO and a 30% dilution).
  • The key is the trade-off between not disrupting the selling process and avoiding any breach of trust. The prevailing local sentiment suggests that KDB and KOBC will choose stock conversion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Crude Oil, Dollar Index, RCI Hospitality Holdings, Ally Financial and more

By | Daily Briefs, United States

In today’s briefing:

  • The Energy Cable #29 – A weak USD paving the way for commodities?
  • DXY Break Below $101 Suggests Breakouts Likely Coming for Equal-Weight SPX, Dow, and Russell 2000
  • RCI Hospitality Holdings, Inc. – Revenues Meet Expectations
  • Ally Financial Earnings: 3 Areas To Focus On


The Energy Cable #29 – A weak USD paving the way for commodities?

By Andreas Steno

  • Welcome to your weekly maverick energy newsletter from both sides of the pond.
  • Stars are starting to align for energy as i) the business cycle seems to be holding up better than feared, ii) the USD is weakening and iii) ongoing supply negative news (prolonged Saudi Arabian supply cut and Russia abandoning the grain deal).
  • Time to go long energy?

DXY Break Below $101 Suggests Breakouts Likely Coming for Equal-Weight SPX, Dow, and Russell 2000

By Joe Jasper

  • Ever since our 5/30/23 ETF Pathfinder, our view has been that we cannot be bearish unless a key support level breaks (at the time, that was 4050 on the SPX).
  • The S&P 500 is now above 4300-4325 — a level that, in January this year, we had anticipated would cap upside for 2023.
  • We believe 4300-4325 will act as major support moving forward, and we are bullish as long as the SPX is above 4300; we discussed this in our 7/3/23 ETF Pathfinder.

RCI Hospitality Holdings, Inc. – Revenues Meet Expectations

By Water Tower Research

  • Multiple Catalysts on the Horizon. Total revenues were essentially in line with our forecast, and we see an attractive runway for growth with at least 10 new locations contributing to revenues through FY24: (1) 4Q23: First full quarter of another Baby Dolls, the reopening of a closed club, and the opening of a new Bombshells, all in Texas; (2) FY24: Opening of two new clubs in Texas, three new Bombshells in Texas and Colorado, and two casinos in Central City, CO. Potential club M&A activity could provide additional upside.

  • Potential club M&A activity could provide additional upside.

  • Nightclubs + Bombshells’ sales increased 8.9% Y/Y. On July 11, RCI announced its preliminary revenues for nightclubs and Bombshells.


Ally Financial Earnings: 3 Areas To Focus On

By Vladimir Dimitrov, CFA

  • Ally Financial is about to release its Q2 2023 earnings tomorrow as tightening within the auto loans market continues.
  • The deposit mix will be a key area to watch as it will have a major impact on the company’s return on tangible common equity.
  • The company is expected to report its second quarter of 2023 on Thursday.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Data#3 Ltd, Ventia, Whitehaven Coal and more

By | Australia, Daily Briefs

In today’s briefing:

  • S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September
  • Ventia Services (VNT) Selected to Join ASX 200 – Not A Surprise
  • Whitehaven Coal June Quarterly: 45% of Mkt Cap in Cash, >20% OCF Yield, Aggressive Buyback


S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September

By Brian Freitas


Ventia Services (VNT) Selected to Join ASX 200 – Not A Surprise

By Travis Lundy

  • After the Blackmores Ltd (BKL AU) Scheme Meeting result was announced earlier today, post-close the S&P/ASX team announced Ventia (VNT AU) would replace it on 21 July at the close.
  • This is not that surprising. Janaghan Jeyakumar, CFA expected it in June, and it was a super-close second recently for him for the Sep rebalance. 
  • Given the shareholder structure and flow dynamics, it’s worth taking a closer look.

Whitehaven Coal June Quarterly: 45% of Mkt Cap in Cash, >20% OCF Yield, Aggressive Buyback

By Sameer Taneja

  • Whitehaven Coal (WHC AU) released its June Quarterly. The company is in blackout (starting July 1st) till its release of annual results on August 24th, 2023.
  • June quarter OCF was 435 mn AUD ( Avg Coal Px 177 USD/ton), and net cash on the balance sheet was 2.65 bn AUD representing 45% of market capitalization.
  • To complete its buyback program, 147 million shares remain left to repurchase (current o/s shares 836 mn). 196 million shares have been repurchased so far since March 2022.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Shenzhen International, Lalatech Holdings Co Ltd, Hong Kong Hang Seng Index, Zhuzhou CRRC Times Electric Co., Ltd., Sino-Ocean Group, Porton Pharma Solutions, Mobvoi and more

By | China, Daily Briefs

In today’s briefing:

  • StubWorld: SZ International’s Logistics Spin-Offs
  • Lalatech IPO: The Bull Case
  • EQD | Hang Seng Index (HSI) WEEKLY Deep-But-Brief Pullback
  • Zhuzhou CRRC Times Electric (3898): Growth at a Discounted Valuation
  • Morning Views Asia: Shui On Land, Sino-Ocean Service
  • Porton Pharma Solutions (300363.CH) 23H1 – Performance Pressure Would Remain in 2023
  • Mobvoi Pre-IPO – Has Turned Profitable but Bulk of Growth Came from a Single Customer


StubWorld: SZ International’s Logistics Spin-Offs

By David Blennerhassett

  • Shenzhen International (152 HK) seeks to spin off logistic assets on a PRC exchange; and  51.56%-held Shenzhen Expressway Co H (548 HK) intends to place out A shares.
  • Preceding my comments on SZ Int’l/SZ E’Way are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Lalatech IPO: The Bull Case

By Arun George

  • Lalatech Holdings Co Ltd (LALA HK), a leading logistics transaction platform, has filed for an HKEx IPO to raise US$1 billion, according to press reports.   
  • Lalatech is the largest logistics transaction platform in the world by closed-loop freight gross transaction value in the first half of 2022, according to Frost & Sullivan. 
  • The key elements of the bull case rest on solid growth, rising monetization rates, achieving maiden profitability, a shift to cash generation and a debt-free balance sheet.

EQD | Hang Seng Index (HSI) WEEKLY Deep-But-Brief Pullback

By Nico Rosti

  • The Hong Kong Hang Seng Index (HSI) last week closed strongly up. This week it’s pulling back, but MRM pattern readings forecast a very short-lived pullback (-1 to -2 weeks).
  • The suggested strategy is: let the index play out its pullback (warning: it can be volatile) and then enter LONG trades when the probability is good.
  • Suggested support price areas are between 18965 (Q2) and 18732 (Q3) – or this Friday at Close (as long as the close is negative).

Zhuzhou CRRC Times Electric (3898): Growth at a Discounted Valuation

By Henry Soediarko

  • The company has shifted its growth driver from rail equipment to EV parts supplier.
  • Q1 23 growth came from emerging equipment coming to the rescue at a double digit rate when the train equipment segment recorded a slight decrease. 
  • Compared to last year, the company is trading at a lower valuation, yet its key growth driver has a better and more sustainable quality. 

Morning Views Asia: Shui On Land, Sino-Ocean Service

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Porton Pharma Solutions (300363.CH) 23H1 – Performance Pressure Would Remain in 2023

By Xinyao (Criss) Wang

  • Porton’s performance declined significantly in 23H1 compared with high base last year, because most of Pfizer’s COVID-19 big orders have been completed. Porton’s performance in 2023 would be under pressure.
  • Porton isn’t a first-tier CXO and lags behind industry leaders in terms of new businesses (CGT/ADC CXO). Valuation of entire CXO sector and Porton hasn’t yet reached an inflection point.
  • Market’s expectation for CXO would decrease and then bottom out in 2023H2. Whether CXO’s performance would rebound in 2024 still needs to wait for the turnaround in macro environment.

Mobvoi Pre-IPO – Has Turned Profitable but Bulk of Growth Came from a Single Customer

By Ethan Aw

  • Mobvoi (2185047D CH) is looking to raise about US$200m in its upcoming Hong Kong IPO. 
  • Mobvoi is an AI company focusing on generative AI and voice interaction technologies. As per CIC, the firm is the largest revenue-generating AI company focusing on AI-generated content in 2022.
  • Mobvoi’s revenue growth was primarily driven by its AI enterprise solutions segment, which led to gross margin expansion and profitability turning positive on all fronts in FY22. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: SAMHI Hotels , Max Healthcare Institute, EbixCash, Freakins and more

By | Daily Briefs, India

In today’s briefing:

  • Samhi Hotels Pre-IPO – Refiling Updates – Bigger Portfolio, Smaller Deal
  • Max Healthcare (MAXHEALTH IN): Record High Sales and Profitability in Q4; Expansion to Drive Growth
  • EbixCash IPO: The Bear Case
  • Freakins Raises $4m Seed Round to Grow Denim Brand


Samhi Hotels Pre-IPO – Refiling Updates – Bigger Portfolio, Smaller Deal

By Sumeet Singh

  • SAMHI Hotels (SAMHI IN)  plans to raise around US$200m (estimated) in its Indian IPO.
  • Samhi is India’s third-largest hotel asset owner, by number of keys, with a portfolio of 25 operating hotel assets comprising 3,839 keys, as of Feb 2023.
  • In this note, we look at its updated filings and discuss the changes since its last filing in 2019.

Max Healthcare (MAXHEALTH IN): Record High Sales and Profitability in Q4; Expansion to Drive Growth

By Tina Banerjee

  • Max Healthcare Institute (MAXHEALT IN) reported robust Q4 performance, with revenue and EBITA increasing 26% and 44%, YoY, respectively. Growth was driven by increase in ARPOB and occupied bed days.
  • Max commissioned new 92 beds oncology block at one of its network hospitals in March. New oncology block contributed positively to revenue and EBITDA in the first month of launch.
  • Max is on track to double its bed capacity in next 5–6 years. Apart from ongoing brownfield expansions, the company has land parcels with potential to add 1,000 beds.

EbixCash IPO: The Bear Case

By Arun George

  • EbixCash (EBIXC IN), a subsidiary of Ebix Inc (EBIX US) and India’s largest end-to-end financial exchange, is seeking to launch an Rs60 billion (US$730 million) in July. 
  • In EbixCash IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The key elements of the bear case rest on margin pressure due to rising operating costs, a related party being the largest customer, declining revenue visibility and deteriorating cash generation.

Freakins Raises $4m Seed Round to Grow Denim Brand

By Tech in Asia

  • India-based fashion brand Freakins has bagged US$4 million in its seed round led by Matrix Partners India and Blume Ventures.
  • Founded in 2021 by Shaan Shah and Puneet Sehgal, Freakins is a direct-to-consumer clothing brand that specializes in denim.
  • The Gen Z-focused firm has built up a catalog of over 1,500 styles, which it says caters to different body types.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars